Woodford Patient Capital holding warns it could go bust
Comes as another portfolio company raises £35m
IP Group
-
-
Unlisted Woodford darling receives £50m injection
California pharma giant invests in Oxford Nanopore
-
Woodford start-up launches £25m funding round
Woodford Patient Capital Trust set to benefit from fresh financing at Genomics
-
Woodford adds to healthcare stock as IP Group sells
Neil Woodford has upped his stake in the soaring healthcare stock Hvivo in the weeks following positive results in a universal flu vaccine, offsetting selling pressure from IP Group, the intellectual property company in which he holds a stake.